The concentrations of the analytes are provided in the lot-specific certificate of analysis.
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Alzheimer’s Disease
,
Neurobiology/Neurodegeneration
|
|
|
Analyte(s)
|
|
Aβ38 (4G8), Aβ40 (4G8), Aβ42 (4G8)
|
|
|
Species
|
|
Human, Mouse, Rat
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
≤-70 °C
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1 (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2 (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3 (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Lecanemab in Early Alzheimer's Disease
|
|
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社